A new zooxanthellate scleractinian coral, Kishi, Nomura & Fukami, (Scleractinia, Merulinidae), is described from non-coral reef regions of Japan and northern Taiwan. This new species was previously recognized as a morphological variant of (Veron, 1990) and can be morphologically distinguished from that species by lacking groove-and-tube structures on corallite wall joints, and by having larger calices, numerous septa, and up to three corallites in one valley. The new species also formed an independent clade from its congeners, (Milne Edwards & Haime, 1857), and (Wells, 1954), in the molecular phylogeny based on the mitochondrial intergenic region and nuclear ribosomal internal transcribed spacers.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11217644PMC
http://dx.doi.org/10.3897/zookeys.1205.121507DOI Listing

Publication Analysis

Top Keywords

kishi nomura
8
nomura fukami
8
japan northern
8
northern taiwan
8
 kishi
4
fukami nov
4
nov cnidaria
4
cnidaria anthozoa
4
anthozoa scleractinia
4
scleractinia coral
4

Similar Publications

CRISPR-Cas9 is a widely used genome-editing tool. We previously developed a method with improved homology-directed repair efficiency and reduced off-target effects by utilizing a fusion protein of AcrIIA4, a Cas9 inhibitor, and Cdt1, which accumulates in the G1 phase and activates Cas9 only in the S/G2 phase. However, it is unknown whether Cas9 inhibition by AcrIIA4 + Cdt1 occurs repeatedly in the G1 phase as the cell cycle progresses.

View Article and Find Full Text PDF

A nationwide questionnaire study evaluated kidney injury associated with Beni-koji tablets in Japan.

Kidney Int

December 2024

Department of Nephrology, Graduate School of Medicine, Osaka University, Suita, Japan. Electronic address:

Red yeast rice, traditionally used in Asian cuisine and increasingly marketed as a dietary supplement for cholesterol management, has recently been linked to kidney dysfunction in Japan. In late 2023 to early 2024, multiple cases involving specific Beni-koji (red yeast rice) tablets from three different Beni-koji preparations, prompted a safety reevaluation. Although citrinin, a known nephrotoxin of red yeast rice, was not produced by the implicated strains, new safety concerns emerged.

View Article and Find Full Text PDF
Article Synopsis
  • The Japanese Society of Mood Disorders (JSMD) updated its bipolar disorder treatment guidelines in 2011, incorporating new research and aligning with the National Academy of Medicine's standards.
  • The guidelines advocate for the use of combination therapy involving mood stabilizers and second-generation antipsychotics, recognizing their effectiveness in treatment.
  • However, they face limitations, as mood stabilizers and antipsychotics were grouped together in analysis due to limited specific evidence for individual drugs, yet still offer valuable clinical support for psychiatrists in Japan.
View Article and Find Full Text PDF
Article Synopsis
  • The WONDER-02 trial is a randomized controlled study aimed at comparing the effectiveness of plastic stents versus lumen-apposing metal stents (LAMSs) for treating symptomatic pancreatic pseudocysts through endoscopic ultrasound (EUS) drainage.
  • The trial will enroll 80 patients from 26 centers in Japan, dividing them into two groups of 40 to receive either type of stent and assessing outcomes like pseudocyst size reduction and overall health improvements.
  • The results will help determine if plastic stents are just as effective as LAMSs, potentially influencing future treatment guidelines for pancreatic pseudocyst patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!